[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Kissei Pharmaceutical Co. Ltd.
Kissei Pharma partners with Viridian Therapeutics for thyroid eye disease therapies in Japan, with strong trial data and a BLA on track for a 2026 U.S. launch. Positive sentiment is high, driven by partnerships and financial performance, but market cap uncertainty remains a concern.
About Kissei Pharmaceutical Co. Ltd.
Kissei Pharmaceutical Co. Ltd. is a Japanese pharmaceutical company.
Price: $ #
Price 24-Hour Time-Series Raw Data
The positive news regarding earnings, licensing agreements, and clinical approvals, combined with the company's dividend hike and share buyback, likely supports the positive sentiment and could be driving the price, although the undefined market cap introduces uncertainty.
1-Year High: $XXXXX on 2025-09-10
1-Year Low: $XXXXX on 2024-12-18
AltRank: undefined #
AltRank 24-Hour Time-Series Raw Data
Kissei Pharmaceutical Co. Ltd. is currently AltRank #undefined based on combined combined social and market metrics
Daily Average: XXXXX
1-Year High: XXXXX on 2025-02-04
1-Year Low: XXX on 2025-03-31
Galaxy Score: XX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-10-12
1-Year Low: X on 2025-08-14
Engagements: XX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Week: XXX -XX%
1 Month: XXXXX -XX%
6 Months: XXXXXX -XX%
1 Year: XXXXXXX +458%
1-Year High: XXXXXX on 2024-11-01
1-Year Low: X on 2024-11-02
| Social Network | X | YouTube |
|---|---|---|
| Engagements | XX | XX |
Mentions: XX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1 Month: XX -XX%
6 Months: XXX +15%
1 Year: XXX +138%
1-Year High: XX on 2025-07-30
1-Year Low: X on 2024-10-30
| Social Network | X | YouTube |
|---|---|---|
| Mentions | XX | X |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Kissei Pharmaceutical Co. Ltd. in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Month: XX -XX%
6 Months: XXX +24%
1 Year: XXX +176%
1-Year High: XX on 2025-07-30
1-Year Low: X on 2024-10-30
The most influential creators that mention Kissei Pharmaceutical Co. Ltd. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @UCBX_5XbOPMaSaKIAfk3iNIA | X | XXXXX | X | XX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% no change
1 Month: XX% +30%
6 Months: XX% -XX%
1 Year: XX% -XX%
1-Year High: XXX% on 2024-11-26
1-Year Low: XX% on 2024-12-19
Most Supportive Themes
- Partnership with Viridian Therapeutics: (60%) Kissei Pharmaceutical's collaboration with Viridian Therapeutics for thyroid eye disease therapies in Japan is a key positive development.
- Financial Performance and Outlook: (25%) Positive earnings, dividend hikes, and share buybacks are likely contributing to the positive sentiment.
Most Critical Themes
- Market Cap Uncertainty: (15%) The undefined market cap introduces uncertainty despite positive news.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | X | X% | XX | XX% | X | X% |
| YouTube | XX | XX% | X | XX% | XX | XX% |
| Total | XX | XX% | XX | XX% | XX | XX% |
Market Cap: $undefined #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $undefined
Daily Average: $XXXXXXXXXXXXXXX
1-Year High: $XXXXXXXXXXXXXXX on 2025-01-06
1-Year Low: $XXXXXXXXXXXXXXX on 2024-12-20
Top assets mentioned In the posts about Kissei Pharmaceutical Co. Ltd. in the last XX hours
Top topics mentioned In the posts about Kissei Pharmaceutical Co. Ltd. in the last XX hours
$vrdn, youtube, $strsta, $5634m, japan, saito, $866m, $202m, $imnn, $celc, $mira, $70m, free fire, #short, ghana, state of, trap, oto, jersey, $rigl
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Spinocerebellar Ataxia Market Dynamics Indicate Upward Trajectory Through 2034 Reports DelveInsight Biohaven VICO Therapeutics IntraBio Kissei Pharmaceutica Steminent Reprocell"
X Link @PressRelease_cc 2025-09-14T17:47Z 1397 followers, XX engagements
"Spinocerebellar Ataxia Market Dynamics Indicate Upward Trajectory Through 2034 Reports DelveInsight Biohaven VICO Therapeutics IntraBio Kissei Pharmaceutica Steminent Reprocell #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech"
X Link @ABNewswire 2025-09-12T16:51Z 1638 followers, XX engagements
"$VRDN +1.5% Viridian Therapeutics highlights veligrotug's Breakthrough Therapy Designation strong trial data and BLA on track for 2H 2025 U.S. launch in 2026. Signed Kissei deal for Japan ($70M upfront). Cash position $563.4M funding operations into 2H 2027"
X Link @notreload_ai 2025-08-06T12:30Z 2934 followers, XXX engagements
"$VRDN Q2 '25: R&D exp $86.6m G&A exp $20.2m Cash $563.4m BTD for veligrotug Kissei deal $70m upfront + $315m milestones. BLA filing 2H25 launch '26. VRDN-006 Ph1 data Q3 XX VRDN-008 IND YE25 Cash runway into 2H '27 PR:"
X Link @FwdQuarter 2025-08-06T11:05Z 1097 followers, XXX engagements